IA_EPA_1 | Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record | |
IA_EPA_2 | Use of telehealth services that expand practice access | |
IA_EPA_3 | Collection and use of patient experience and satisfaction data on access | |
IA_EPA_4 | Additional improvements in access as a result of QIN/QIO TA | |
IA_EPA_5 | Participation in User Testing of the Quality Payment Program Website (https://qpp.cms.gov/) | |
IA_PM_2 | Anticoagulant Management Improvements | |
IA_PM_3 | RHC, IHS or FQHC quality improvement activities | |
IA_PM_4 | Glycemic management services | |
IA_PM_5 | Engagement of community for health status improvement | |
IA_PM_6 | Use of toolsets or other resources to close healthcare disparities across communities | |
IA_PM_7 | Use of QCDR for feedback reports that incorporate population health | |
IA_PM_11 | Regular Review Practices in Place on Targeted Patient Population Needs | |
IA_PM_12 | Population empanelment | |
IA_PM_13 | Chronic Care and Preventative Care Management for Empaneled Patients | |
IA_PM_14 | Implementation of methodologies for improvements in longitudinal care management for high risk patients | |
IA_PM_15 | Implementation of episodic care management practice improvements | |
IA_PM_16 | Implementation of medication management practice improvements | |
IA_PM_17 | Participation in Population Health Research | |
IA_PM_18 | Provide Clinical-Community Linkages | |
IA_PM_19 | Glycemic Screening Services | |
IA_PM_20 | Glycemic Referring Services | |
IA_PM_21 | Advance Care Planning | |
IA_CC_1 | Implementation of Use of Specialist Reports Back to Referring Clinician or Group to Close Referral Loop | |
IA_CC_2 | Implementation of improvements that contribute to more timely communication of test results | |
IA_CC_7 | Regular training in care coordination | |
IA_CC_8 | Implementation of documentation improvements for practice/process improvements | |
IA_CC_9 | Implementation of practices/processes for developing regular individual care plans | |
IA_CC_10 | Care transition documentation practice improvements | |
IA_CC_11 | Care transition standard operational improvements | |
IA_CC_12 | Care coordination agreements that promote improvements in patient tracking across settings | |
IA_CC_13 | Practice Improvements for Bilateral Exchange of Patient Information | |
IA_CC_14 | Practice Improvements that Engage Community Resources to Support Patient Health Goals | |
IA_CC_15 | PSH Care Coordination | |
IA_CC_16 | Primary Care Physician and Behavioral Health Bilateral Electronic Exchange of Information for Shared Patients | |
IA_CC_17 | Patient Navigator Program | |
IA_CC_18 | Relationship-Centered Communication | |
IA_CC_19 | Tracking of clinician’s relationship to and responsibility for a patient by reporting MACRA patient relationship codes. | |
IA_BE_1 | Use of certified EHR to capture patient reported outcomes | |
IA_BE_3 | Engagement with QIN-QIO to implement self-management training programs | |
IA_BE_4 | Engagement of patients through implementation of improvements in patient portal | |
IA_BE_5 | Enhancements/regular updates to practice websites/tools that also include considerations for patients with cognitive disabilities | |
IA_BE_6 | Collection and follow-up on patient experience and satisfaction data on beneficiary engagement | |
IA_BE_7 | Participation in a QCDR, that promotes use of patient engagement tools. | |
IA_BE_8 | Participation in a QCDR, that promotes collaborative learning network opportunities that are interactive. | |
IA_BE_12 | Use evidence-based decision aids to support shared decision-making. | |
IA_BE_13 | Regularly assess the patient experience of care through surveys, advisory councils and/or other mechanisms. | |
IA_BE_14 | Engage Patients and Families to Guide Improvement in the System of Care | |
IA_BE_15 | Engagement of Patients, Family, and Caregivers in Developing a Plan of Care | |
IA_BE_16 | Evidenced-based techniques to promote self-management into usual care | |
IA_BE_17 | Use of tools to assist patient self-management | |
IA_BE_18 | Provide peer-led support for self-management. | |
IA_BE_19 | Use group visits for common chronic conditions (e.g., diabetes). | |
IA_BE_20 | Implementation of condition-specific chronic disease self-management support programs | |
IA_BE_21 | Improved Practices that Disseminate Appropriate Self-Management Materials | |
IA_BE_22 | Improved Practices that Engage Patients Pre-Visit | |
IA_BE_23 | Integration of patient coaching practices between visits | |
IA_BE_24 | Financial Navigation Program | |
IA_BE_25 | Drug Cost Transparency | |
IA_PSPA_1 | Participation in an AHRQ-listed patient safety organization. | |
IA_PSPA_2 | Participation in MOC Part IV | |
IA_PSPA_3 | Participate in IHI Training/Forum Event; National Academy of Medicine, AHRQ Team STEPPS or Other Similar Activity | |
IA_PSPA_4 | Administration of the AHRQ Survey of Patient Safety Culture | |
IA_PSPA_6 | Consultation of the Prescription Drug Monitoring Program | |
IA_PSPA_7 | Use of QCDR data for ongoing practice assessment and improvements | |
IA_PSPA_8 | Use of Patient Safety Tools | |
IA_PSPA_9 | Completion of the AMA STEPS Forward program | |
IA_PSPA_10 | Completion of training and receipt of approved waiver for provision opioid medication-assisted treatments | |
IA_PSPA_11 | Participation in CAHPS or other supplemental questionnaire | |
IA_PSPA_12 | Participation in private payer CPIA | |
IA_PSPA_13 | Participation in Joint Commission Evaluation Initiative | |
IA_PSPA_15 | Implementation of an ASP | |
IA_PSPA_16 | Use of decision support and standardized treatment protocols | |
IA_PSPA_17 | Implementation of analytic capabilities to manage total cost of care for practice population | |
IA_PSPA_18 | Measurement and Improvement at the Practice and Panel Level | |
IA_PSPA_19 | Implementation of formal quality improvement methods, practice changes, or other practice improvement processes | |
IA_PSPA_20 | Leadership engagement in regular guidance and demonstrated commitment for implementing practice improvement changes | |
IA_PSPA_21 | Implementation of fall screening and assessment programs | |
IA_PSPA_22 | CDC Training on CDC's Guideline for Prescribing Opioids for Chronic Pain | |
IA_PSPA_23 | Completion of CDC Training on Antibiotic Stewardship | |
IA_PSPA_25 | Cost Display for Laboratory and Radiographic Orders | |
IA_PSPA_26 | Communication of Unscheduled Visit for Adverse Drug Event and Nature of Event | |
IA_PSPA_27 | Invasive Procedure or Surgery Anticoagulation Medication Management | |
IA_PSPA_28 | Completion of an Accredited Safety or Quality Improvement Program | |
IA_PSPA_29 | Consulting AUC Using Clinical Decision Support when Ordering Advanced | |
IA_PSPA_30 | PCI Bleeding Campaign | |
IA_PSPA_31 | Patient Medication Risk Education | |
IA_PSPA_32 | Use of CDC Guideline for Clinical Decision Support to Prescribe Opioids for Chronic Pain via Clinical Decision Support | |
IA_AHE_1 | Engagement of New Medicaid Patients and Follow-up | |
IA_AHE_3 | Promote Use of Patient-Reported Outcome Tools | |
IA_AHE_5 | MIPS Eligible Clinician Leadership in Clinical Trials or CBPR | |
IA_AHE_6 | Provide Education Opportunities for New Clinicians | |
IA_AHE_7 | Comprehensive Eye Exams | |
IA_ERP_1 | Participation on Disaster Medical Assistance Team, registered for 6 months. | |
IA_ERP_2 | Participation in a 60-day or greater effort to support domestic or international humanitarian needs. | |
IA_ERP_3 | COVID-19 Clinical Data Reporting with or without Clinical Trial | |
IA_BMH_1 | Diabetes screening | |
IA_BMH_2 | Tobacco use | |
IA_BMH_4 | Depression screening | |
IA_BMH_5 | MDD prevention and treatment interventions | |
IA_BMH_6 | Implementation of co-location PCP and MH services | |
IA_BMH_7 | Implementation of Integrated Patient Centered Behavioral Health Model | |
IA_BMH_8 | Electronic Health Record Enhancements for BH data capture | |
IA_BMH_9 | Unhealthy Alcohol Use for Patients with Co-occurring Conditions of Mental Health and Substance Abuse and Ambulatory Care Patients | |
IA_BMH_10 | Completion of Collaborative Care Management Training Program | |
IA_PCMH | Electronic submission of Patient Centered Medical Home accreditation | |
PI_PPHI_1 | Security Risk Analysis | |
PI_ONCDIR_1 | ONC Direct Review Attestation | |
PI_INFBLO_1 | Prevention of Information Blocking Attestation | |
PI_ONCACB_1 | ONC-ACB Surveillance Attestation | |
PI_EP_1 | e-Prescribing | |
PI_LVPP_1 | e-Prescribing Exclusion | |
PI_EP_2 | Query of the Prescription Drug Monitoring Program (PDMP) | |
PI_HIE_1 | Support Electronic Referral Loops By Sending Health Information | |
PI_LVOTC_1 | Support Electronic Referral Loops By Sending Health Information Exclusion | |
PI_HIE_4 | Support Electronic Referral Loops By Receiving and Reconciling Health Information | |
PI_LVITC_2 | Support Electronic Referral Loops By Receiving and Reconciling Health Information Exclusion | |
PI_HIE_5 | Health Information Exchange(HIE) Bi-Directional Exchange | |
PI_PEA_1 | Provide Patients Electronic Access to Their Health Information | |
PI_PHCDRR_2 | Syndromic Surveillance Reporting | |
PI_PHCDRR_2_MULTI | Syndromic Surveillance Reporting for Multiple Registry Engagement | |
PI_PHCDRR_2_EX_1 | Syndromic Surveillance Reporting Exclusion | |
PI_PHCDRR_2_EX_2 | Syndromic Surveillance Reporting Exclusion | |
PI_PHCDRR_2_EX_3 | Syndromic Surveillance Reporting Exclusion | |
PI_PHCDRR_1 | Immunization Registry Reporting | |
PI_PHCDRR_1_MULTI | Immunization Registry Reporting for Multiple Registry Engagement | |
PI_PHCDRR_1_EX_1 | Immunization Registry Reporting Exclusion | |
PI_PHCDRR_1_EX_2 | Immunization Registry Reporting Exclusion | |
PI_PHCDRR_1_EX_3 | Immunization Registry Reporting Exclusion | |
PI_PHCDRR_3 | Electronic Case Reporting | |
PI_PHCDRR_3_MULTI | Electronic Case Reporting for Multiple Registry Engagement | |
PI_PHCDRR_3_EX_1 | Electronic Case Reporting Exclusion | |
PI_PHCDRR_3_EX_2 | Electronic Case Reporting Exclusion | |
PI_PHCDRR_3_EX_3 | Electronic Case Reporting Exclusion | |
PI_PHCDRR_4 | Public Health Registry Reporting | |
PI_PHCDRR_4_MULTI | Public Health Registry Reporting for Multiple Registry Engagement | |
PI_PHCDRR_4_EX_1 | Public Health Registry Reporting Exclusion | |
PI_PHCDRR_4_EX_2 | Public Health Registry Reporting Exclusion | |
PI_PHCDRR_4_EX_3 | Public Health Registry Reporting Exclusion | |
PI_PHCDRR_5 | Clinical Data Registry Reporting | |
PI_PHCDRR_5_MULTI | Clinical Data Registry Reporting for Multiple Registry Engagement | |
PI_PHCDRR_5_EX_1 | Clinical Data Registry Reporting Exclusion | |
PI_PHCDRR_5_EX_2 | Clinical Data Registry Reporting Exclusion | |
PI_PHCDRR_5_EX_3 | Clinical Data Registry Reporting Exclusion | |
001 | Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) | Claims, Electronic Health Record, Cms Web Interface, Registry |
005 | Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) | Electronic Health Record, Registry |
006 | Coronary Artery Disease (CAD): Antiplatelet Therapy | Registry |
007 | Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) | Electronic Health Record, Registry |
008 | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) | Electronic Health Record, Registry |
009 | Anti-Depressant Medication Management | Electronic Health Record |
012 | Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation | Electronic Health Record |
014 | Age-Related Macular Degeneration (AMD): Dilated Macular Examination | Claims, Registry |
019 | Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care | Electronic Health Record, Registry |
021 | Perioperative Care: Selection of Prophylactic Antibiotic – First OR Second-Generation Cephalosporin | Claims, Registry |
023 | Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) | Claims, Registry |
024 | Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older | Claims, Registry |
039 | Screening for Osteoporosis for Women Aged 65-85 Years of Age | Claims, Registry |
044 | Coronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG Surgery | Registry |
047 | Advance Care Plan | Claims, Registry |
048 | Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older | Registry |
050 | Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older | Claims, Registry |
052 | Chronic Obstructive Pulmonary Disease (COPD): Long-Acting Inhaled Bronchodilator Therapy | Registry |
065 | Appropriate Treatment for Upper Respiratory Infection (URI) | Electronic Health Record, Registry |
066 | Appropriate Testing for Pharyngitis | Electronic Health Record, Registry |
067 | Hematology: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow | Registry |
070 | Hematology: Chronic Lymphocytic Leukemia (CLL): Baseline Flow Cytometry | Registry |
076 | Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections | Claims, Registry |
093 | Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy – Avoidance of Inappropriate Use | Claims, Registry |
102 | Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients | Electronic Health Record, Registry |
104 | Prostate Cancer: Combination Androgen Deprivation Therapy for High Risk or Very High Risk Prostate Cancer | Registry |
107 | Adult Major Depressive Disorder (MDD): Suicide Risk Assessment | Electronic Health Record |
110 | Preventive Care and Screening: Influenza Immunization | Claims, Electronic Health Record, Cms Web Interface, Registry |
111 | Pneumococcal Vaccination Status for Older Adults | Claims, Electronic Health Record, Registry |
112 | Breast Cancer Screening | Claims, Electronic Health Record, Cms Web Interface, Registry |
113 | Colorectal Cancer Screening | Claims, Electronic Health Record, Cms Web Interface, Registry |
116 | Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis | Registry |
117 | Diabetes: Eye Exam | Claims, Electronic Health Record, Registry |
118 | Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%) | Registry |
119 | Diabetes: Medical Attention for Nephropathy | Electronic Health Record, Registry |
126 | Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy – Neurological Evaluation | Registry |
127 | Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of Footwear | Registry |
128 | Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan | Claims, Electronic Health Record, Registry |
130 | Documentation of Current Medications in the Medical Record | Claims, Electronic Health Record, Registry |
134 | Preventive Care and Screening: Screening for Depression and Follow-Up Plan | Claims, Electronic Health Record, Cms Web Interface, Registry |
137 | Melanoma: Continuity of Care – Recall System | Registry |
138 | Melanoma: Coordination of Care | Registry |
141 | Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Documentation of a Plan of Care | Claims, Registry |
143 | Oncology: Medical and Radiation – Pain Intensity Quantified | Electronic Health Record, Registry |
144 | Oncology: Medical and Radiation - Plan of Care for Pain | Registry |
145 | Radiology: Exposure Dose Indices or Exposure Time and Number of Images Reported for Procedures Using Fluoroscopy | Claims, Registry |
147 | Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy | Claims, Registry |
154 | Falls: Risk Assessment | Claims, Registry |
155 | Falls: Plan of Care | Claims, Registry |
164 | Coronary Artery Bypass Graft (CABG): Prolonged Intubation | Registry |
167 | Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure | Registry |
168 | Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration | Registry |
176 | Tuberculosis Screening Prior to First Course Biologic Therapy | Registry |
177 | Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity | Registry |
178 | Rheumatoid Arthritis (RA): Functional Status Assessment | Registry |
180 | Rheumatoid Arthritis (RA): Glucocorticoid Management | Registry |
181 | Elder Maltreatment Screen and Follow-Up Plan | Claims, Registry |
182 | Functional Outcome Assessment | Claims, Registry |
185 | Colonoscopy Interval for Patients with a History of Adenomatous Polyps – Avoidance of Inappropriate Use | Registry |
187 | Stroke and Stroke Rehabilitation: Thrombolytic Therapy | Registry |
191 | Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery | Electronic Health Record, Registry |
195 | Radiology: Stenosis Measurement in Carotid Imaging Reports | Claims, Registry |
205 | HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphilis | Registry |
217 | Functional Status Change for Patients with Knee Impairments | Registry |
218 | Functional Status Change for Patients with Hip Impairments | Registry |
219 | Functional Status Change for Patients with Lower Leg, Foot or Ankle Impairments | Registry |
220 | Functional Status Change for Patients with Low Back Impairments | Registry |
221 | Functional Status Change for Patients with Shoulder Impairments | Registry |
222 | Functional Status Change for Patients with Elbow, Wrist or Hand Impairments | Registry |
225 | Radiology: Reminder System for Screening Mammograms | Claims, Registry |
226 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | Claims, Electronic Health Record, Cms Web Interface, Registry |
236 | Controlling High Blood Pressure | Claims, Electronic Health Record, Cms Web Interface, Registry |
238 | Use of High-Risk Medications in Older Adults | Electronic Health Record, Registry |
239 | Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents | Electronic Health Record |
240 | Childhood Immunization Status | Electronic Health Record |
243 | Cardiac Rehabilitation Patient Referral from an Outpatient Setting | Registry |
249 | Barrett’s Esophagus | Claims, Registry |
250 | Radical Prostatectomy Pathology Reporting | Claims, Registry |
254 | Ultrasound Determination of Pregnancy Location for Pregnant Patients with Abdominal Pain | Claims, Registry |
258 | Rate of Open Repair of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #7) | Registry |
259 | Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #2) | Registry |
260 | Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2) | Registry |
261 | Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness | Claims, Registry |
264 | Sentinel Lymph Node Biopsy for Invasive Breast Cancer | Registry |
265 | Biopsy Follow-Up | Registry |
268 | Epilepsy: Counseling for Women of Childbearing Potential with Epilepsy | Registry |
275 | Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy | Registry |
277 | Sleep Apnea: Severity Assessment at Initial Diagnosis | Registry |
279 | Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy | Registry |
281 | Dementia: Cognitive Assessment | Electronic Health Record |
282 | Dementia: Functional Status Assessment | Registry |
283 | Dementia Associated Behavioral and Psychiatric Symptoms Screening and Management | Registry |
286 | Dementia: Safety Concern Screening and Follow-Up for Patients with Dementia | Registry |
288 | Dementia: Education and Support of Caregivers for Patients with Dementia | Registry |
290 | Parkinson’s Disease: Psychiatric Symptoms Assessment for Patients with Parkinson’s Disease | Registry |
291 | Parkinson’s Disease: Cognitive Impairment or Dysfunction Assessment for Patients with Parkinson's Disease | Registry |
293 | Parkinson’s Disease: Rehabilitative Therapy Options | Registry |
303 | Cataracts: Improvement in Patient’s Visual Function within 90 Days Following Cataract Surgery | Registry |
304 | Cataracts: Patient Satisfaction within 90 Days Following Cataract Surgery | Registry |
305 | Initiation and Engagement of Alcohol and Other Drug Dependence Treatment | Electronic Health Record |
309 | Cervical Cancer Screening | Electronic Health Record |
310 | Chlamydia Screening for Women | Electronic Health Record |
317 | Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented | Claims, Electronic Health Record, Registry |
318 | Falls: Screening for Future Fall Risk | Electronic Health Record, Cms Web Interface |
320 | Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients | Claims, Registry |
321 | CAHPS for MIPs Clinician/Group Survey | Certified Survey Vendor |
322 | Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low-Risk Surgery Patients | Registry |
323 | Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coronary Intervention (PCI) | Registry |
324 | Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asymptomatic, Low-Risk Patients | Registry |
326 | Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy | Claims, Registry |
331 | Adult Sinusitis: Antibiotic Prescribed for Acute Viral Sinusitis (Overuse) | Registry |
332 | Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use) | Registry |
335 | Maternity Care: Elective Delivery or Early Induction Without Medical Indication at < 39 Weeks (Overuse) | Registry |
336 | Maternity Care: Postpartum Follow-up and Care Coordination | Registry |
337 | Psoriasis: Tuberculosis (TB) Prevention for Patients with Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis on a Biological Immune Response Modifier | Registry |
338 | HIV Viral Load Suppression | Registry |
340 | HIV Medical Visit Frequency | Registry |
342 | Pain Brought Under Control Within 48 Hours | Registry |
344 | Rate of Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2) | Registry |
350 | Total Knee Replacement: Shared Decision-Making: Trial of Conservative (Non-surgical) Therapy | Registry |
351 | Total Knee Replacement: Venous Thromboembolic and Cardiovascular Risk Evaluation | Registry |
354 | Anastomotic Leak Intervention | Registry |
355 | Unplanned Reoperation within the 30 Day Postoperative Period | Registry |
356 | Unplanned Hospital Readmission within 30 Days of Principal Procedure | Registry |
357 | Surgical Site Infection (SSI) | Registry |
358 | Patient-Centered Surgical Risk Assessment and Communication | Registry |
360 | Optimizing Patient Exposure to Ionizing Radiation: Count of Potential High Dose Radiation Imaging Studies: Computed Tomography (CT) and Cardiac Nuclear Medicine Studies | Registry |
364 | Optimizing Patient Exposure to Ionizing Radiation: Appropriateness: Follow-up CT Imaging for Incidentally Detected Pulmonary Nodules According to Recommended Guidelines | Registry |
366 | Follow-Up Care for Children Prescribed ADHD Medication (ADD) | Electronic Health Record |
370 | Depression Remission at Twelve Months | Electronic Health Record, Cms Web Interface, Registry |
374 | Closing the Referral Loop: Receipt of Specialist Report | Electronic Health Record, Registry |
375 | Functional Status Assessment for Total Knee Replacement | Electronic Health Record |
376 | Functional Status Assessment for Total Hip Replacement | Electronic Health Record |
377 | Functional Status Assessments for Congestive Heart Failure | Electronic Health Record |
378 | Children Who Have Dental Decay or Cavities | Electronic Health Record |
379 | Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists | Electronic Health Record |
382 | Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment | Electronic Health Record |
383 | Adherence to Antipsychotic Medications For Individuals with Schizophrenia | Registry |
384 | Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the Operating Room Within 90 Days of Surgery | Registry |
385 | Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement Within 90 Days of Surgery | Registry |
386 | Amyotrophic Lateral Sclerosis (ALS) Patient Care Preferences | Registry |
387 | Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users | Registry |
389 | Cataract Surgery: Difference Between Planned and Final Refraction | Registry |
391 | Follow-Up After Hospitalization for Mental Illness (FUH) | Registry |
392 | Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation Ablation | Registry |
393 | Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or Revision | Registry |
394 | Immunizations for Adolescents | Registry |
395 | Lung Cancer Reporting (Biopsy/Cytology Specimens) | Claims, Registry |
396 | Lung Cancer Reporting (Resection Specimens) | Claims, Registry |
397 | Melanoma Reporting | Claims, Registry |
398 | Optimal Asthma Control | Registry |
400 | One-Time Screening for Hepatitis C Virus (HCV) for Patients at Risk | Registry |
401 | Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis | Registry |
402 | Tobacco Use and Help with Quitting Among Adolescents | Registry |
404 | Anesthesiology Smoking Abstinence | Registry |
405 | Appropriate Follow-up Imaging for Incidental Abdominal Lesions | Claims, Registry |
406 | Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients | Claims, Registry |
409 | Clinical Outcome Post Endovascular Stroke Treatment | Registry |
410 | Psoriasis: Clinical Response to Systemic Medications | Registry |
413 | Door to Puncture Time for Endovascular Stroke Treatment | Registry |
415 | Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older | Registry |
416 | Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 Years | Claims, Registry |
418 | Osteoporosis Management in Women Who Had a Fracture | Claims, Registry |
419 | Overuse of Imaging for the Evaluation of Primary Headache | Registry |
420 | Varicose Vein Treatment with Saphenous Ablation: Outcome Survey | Registry |
421 | Appropriate Assessment of Retrievable Inferior Vena Cava (IVC) Filters for Removal | Registry |
422 | Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury | Claims, Registry |
424 | Perioperative Temperature Management | Registry |
425 | Photodocumentation of Cecal Intubation | Claims, Registry |
429 | Pelvic Organ Prolapse: Preoperative Screening for Uterine Malignancy | Claims, Registry |
430 | Prevention of Post-Operative Nausea and Vomiting (PONV) – Combination Therapy | Registry |
431 | Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling | Registry |
432 | Proportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse Repair | Registry |
433 | Proportion of Patients Sustaining a Bowel Injury at the time of any Pelvic Organ Prolapse Repair | Registry |
434 | Proportion of Patients Sustaining a Ureter Injury at the Time of Pelvic Organ Prolapse Repair | Registry |
436 | Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques | Claims, Registry |
438 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | Electronic Health Record, Cms Web Interface, Registry |
439 | Age Appropriate Screening Colonoscopy | Registry |
440 | Skin Cancer: Biopsy Reporting Time – Pathologist to Clinician | Registry |
441 | Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control) | Registry |
443 | Non-Recommended Cervical Cancer Screening in Adolescent Females | Registry |
444 | Medication Management for People with Asthma | Registry |
445 | Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG) | Registry |
448 | Appropriate Workup Prior to Endometrial Ablation | Registry |
450 | Appropriate Treatment for Patients with Stage I (T1c) - III HER2 Positive Breast Cancer | Registry |
451 | RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy | Registry |
452 | Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies | Registry |
453 | Percentage of Patients Who Died from Cancer Receiving Chemotherapy in the Last 14 Days of Life (lower score – better) | Registry |
455 | Percentage of Patients Who Died from Cancer Admitted to the Intensive Care Unit (ICU) in the Last 30 Days of Life (lower score – better) | Registry |
457 | Percentage of Patients Who Died from Cancer Admitted to Hospice for Less than 3 days (lower score – better) | Registry |
459 | Back Pain After Lumbar Discectomy/Laminectomy | Registry |
460 | Back Pain After Lumbar Fusion | Registry |
461 | Leg Pain After Lumbar Discectomy/Laminectomy | Registry |
462 | Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy | Electronic Health Record |
463 | Prevention of Post-Operative Vomiting (POV) – Combination Therapy (Pediatrics) | Registry |
464 | Otitis Media with Effusion: Systemic Antimicrobials - Avoidance of Inappropriate Use | Registry |
465 | Uterine Artery Embolization Technique: Documentation of Angiographic Endpoints and Interrogation of Ovarian Arteries | Registry |
468 | Continuity of Pharmacotherapy for Opioid Use Disorder (OUD) | Registry |
469 | Functional Status After Lumbar Fusion | Registry |
470 | Functional Status After Primary Total Knee Replacement | Registry |
471 | Functional Status After Lumbar Discectomy/Laminectomy | Registry |
472 | Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture | Electronic Health Record |
473 | Leg Pain After Lumbar Fusion | Registry |
475 | HIV Screening | Electronic Health Record |
476 | Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia | Electronic Health Record |
477 | Multimodal Pain Management | Registry |
478 | Functional Status Change for Patients with Neck Impairments | Registry |
479 | Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for the Merit-Based Incentive Payment System (MIPS) Groups | Administrative Claims |
480 | Risk-standardized complication rate (RSCR) following elective primary total hip arthroplasty (THA) and/or total knee arthroplasty (TKA) for Merit-based Incentive Payment System (MIPS) | Administrative Claims |
MCC1 | All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC) | Administrative Claims |
MSPB_1 | Medicare Spending Per Beneficiary (MSPB) | Administrative Claims |
TPCC_1 | Total Per Capita Costs (TPCC) | Administrative Claims |
COST_IOL_1 | Routine Cataract Removal with Intraocular Lens (IOL) Implantation | Administrative Claims |
COST_IHCI_1 | Intracranial Hemorrhage or Cerebral Infarction | Administrative Claims |
COST_KA_1 | Knee Arthroplasty | Administrative Claims |
COST_EOPCI_1 | Elective Outpatient Percutaneous Coronary Intervention (PCI) | Administrative Claims |
COST_SPH_1 | Simple Pneumonia with Hospitalization | Administrative Claims |
COST_CCLI_1 | Revascularization for Lower Extremity Chronic Critical Limb Ischemia | Administrative Claims |
COST_SSC_1 | Screening/Surveillance Colonoscopy | Administrative Claims |
COST_STEMI_1 | ST-Elevation Myocardial Infarction (STEMI) with Percutaneous Coronary Intervention (PCI) | Administrative Claims |
COST_AKID_1 | Acute Kidney Injury Requiring New Inpatient Dialysis | Administrative Claims |
COST_PHA_1 | Elective Primary Hip Arthroplasty | Administrative Claims |
COST_FIHR_1 | Femoral or Inguinal Hernia Repair | Administrative Claims |
COST_HAC_1 | Hemodialysis Access Creation | Administrative Claims |
COST_COPDE_1 | Inpatient Chronic Obstructive Pulmonary Disease (COPD) Exacerbation | Administrative Claims |
COST_LGH_1 | Lower Gastrointestinal Hemorrhage (groups only) | Administrative Claims |
COST_LSFDD_1 | Lumbar Spine Fusion for Degenerative Disease, 1-3 Levels | Administrative Claims |
COST_LPMSM_1 | Lumpectomy Partial Mastectomy, Simple Mastectomy | Administrative Claims |
COST_NECABG_1 | Non-Emergent Coronary Artery Bypass Graft (CABG) | Administrative Claims |
COST_RUSST_1 | Renal or Ureteral Stone Surgical Treatment | Administrative Claims |
CAHPS_1 | CAHPS for MIPS SSM: Getting Timely Care, Appointments, and Information | Certified Survey Vendor |
CAHPS_2 | CAHPS for MIPS SSM: How Well Providers Communicate | Certified Survey Vendor |
CAHPS_3 | CAHPS for MIPS SSM: Patient’s Rating of Provider | Certified Survey Vendor |
CAHPS_4 | CAHPS for MIPS SSM: Access to Specialists | Certified Survey Vendor |
CAHPS_5 | CAHPS for MIPS SSM: Health Promotion and Education | Certified Survey Vendor |
CAHPS_6 | CAHPS for MIPS SSM: Shared Decision Making | Certified Survey Vendor |
CAHPS_7 | CAHPS for MIPS SSM: Health Status and Functional Status | Certified Survey Vendor |
CAHPS_8 | CAHPS for MIPS SSM: Care Coordination | Certified Survey Vendor |
CAHPS_9 | CAHPS for MIPS SSM: Courteous and Helpful Office Staff | Certified Survey Vendor |
CAHPS_11 | CAHPS for MIPS SSM: Stewardship of Patient Resources | Certified Survey Vendor |
AAAAI17 | Asthma Control: Minimal Important Difference Improvement | Registry |
AAAAI18 | Penicillin Allergy: Appropriate Removal or Confirmation | Registry |
AAAAI2 | Asthma: Assessment of Asthma Control – Ambulatory Care Setting | Registry |
AAAAI6 | Documentation of Clinical Response to Allergen Immunotherapy within One Year | Registry |
AAAAI8 | Achievement of Projected Effective Dose of Standardized Allergens for Patient Treated With Allergen Immunotherapy for at Least One Year | Registry |
AAD10 | Dermatitis – Improvement in Patient-Reported Itch Severity | Registry |
AAD11 | Skin Cancer Surgery: Post-Operative Complications | Registry |
AAD12 | Melanoma: – Appropriate Surgical Margins | Registry |
AAD6 | Skin Cancer: Biopsy Reporting Time - Clinician to Patient | Registry |
AAD7 | Psoriasis: Screening for Psoriatic Arthritis | Registry |
AAD8 | Chronic Skin Conditions: Patient Reported Quality-of-Life | Registry |
AAD9 | Psoriasis – Improvement in Patient-Reported Itch Severity | Registry |
AAN22 | Quality of Life Outcome for Patients with Neurologic Conditions | Registry |
AAN25 | Pediatric Medication reconciliation | Registry |
AAN26 | Activity counseling for back pain | Registry |
AAN28 | Diabetes/Pre-Diabetes Screening for Patients with DSP | Registry |
AAN29 | Comprehensive Epilepsy Care Center Referral or Discussion for Patients with Epilepsy | Registry |
AAN30 | Migraine Preventive Therapy Management | Registry |
AAN31 | Acute Treatment Prescribed for Cluster Headache | Registry |
AAN32 | Preventive Treatment Prescribed for Cluster Headache | Registry |
AAN33 | Fatigue Screening and Follow-Up for Patients with MS | Registry |
AAN34 | Patient reported falls and plan of care | Registry |
AAN5 | Medication Prescribed For Acute Migraine Attack | Registry |
AAN8 | Exercise and Appropriate Physical Activity Counseling for Patients with MS | Registry |
AAN9 | Querying About Symptoms of Autonomic Dysfunction for Patients with Parkinson's Disease | Registry |
AAO12 | Tympanostomy Tubes: Topical Ear Drop Monotherapy Acute Otorrhea | Registry |
AAO13 | Bell's Palsy: Inappropriate Use of Magnetic Resonance Imaging or Computed Tomography Scan (Inverse Measure) | Registry |
AAO16 | Age-related Hearing Loss: Audiometric Evaluation | Registry |
AAO20 | Tympanostomy Tubes: Hearing Test | Registry |
AAO21 | Otitis Media with Effusion: Hearing Test for Chronic OME > 3 months | Registry |
AAO23 | Allergic Rhinitis: Intranasal Corticosteroids or Oral Antihistamines | Registry |
AAO24 | Allergic Rhinitis: Avoidance of Leukotriene Inhibitors | Registry |
AAO29 | Quality of Life for Patients with Neurotology Disorders | Registry |
AAO31 | Otitis Media with Effusion (OME): Avoidance of Inappropriate Use of Medications | Registry |
AAO32 | Standard BPPV Management | Registry |
AAO34 | Dysphonia: Postoperative Laryngeal Examination | Registry |
AAO35 | Benign Positional Paroxysmal Vertigo (BPPV): Dix-Hallpike and Canalith Repositioning | Registry |
AAO36 | Tympanostomy Tubes: Resolution of Otitis Media with Effusion in Adults and Children | Registry |
AASM1 | Pediatric OSA: Objective Assessment of Positive Airway Pressure Therapy Adherence | Registry |
AASM2 | Pediatric OSA: Objective Assessment of OSA Signs and Symptoms in Children with Complex Medical Conditions | Registry |
AASM3 | Adult OSA: Screening for Adult OSA by Primary Care Physicians | Registry |
ABFM11 | Person-Centered Primary Care Measure Performance Measure (PCPCM PRO-PM) | Registry |
ABFM9 | Measuring the Value-Functions of Primary Care: Provider Level Continuity Measure | Registry |
ABG40 | Hypotension Prevention After Spinal Placement for Elective Cesarean Section | Registry |
ABG41 | Upper Extremity Nerve Blockade in Shoulder Surgery | Registry |
ABG42 | Known or Suspected Difficult Airway Mitigation Strategies | Registry |
ACCPIN11 | Heart Failure: Patient Self Care Education | Registry |
ACCPIN7 | Peripheral Artery Disease: Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk | Registry |
ACCPIN8 | Hypertension Control (Stage 1 or 2) | Registry |
ACEP19 | Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older | Registry |
ACEP21 | Coagulation Studies in Patients Presenting with Chest Pain with No Coagulopathy or Bleeding | Registry |
ACEP22 | Appropriate Emergency Department Utilization of CT for Pulmonary Embolism | Registry |
ACEP25 | Tobacco Use: Screening and Cessation Intervention for Patients with Asthma and COPD | Registry |
ACEP30 | Sepsis Management: Septic Shock: Lactate Clearance Rate of ≥ 10% | Registry |
ACEP31 | Appropriate Foley catheter use in the emergency department | Registry |
ACEP48 | Sepsis Management: Septic Shock: Lactate Level Measurement, Antibiotics Ordered, and Fluid Resuscitation | Registry |
ACEP50 | ED Median Time from ED arrival to ED departure for all Adult Patients | Registry |
ACEP51 | ED Median Time from ED arrival to ED departure for all Pediatric Patients | Registry |
ACEP52 | Appropriate Emergency Department Utilization of Lumbar Spine Imaging for Atraumatic Low Back Pain | Registry |
ACEP53 | Appropriate Use of Imaging for Recurrent Renal Colic | Registry |
ACEP54 | Appropriate Utilization of FAST Exam in the Emergency Department | Registry |
ACEP55 | Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 Years | Registry |
ACEP56 | Follow-Up Care Coordination Documented in Discharge Summary | Registry |
ACEP57 | Avoidance of Opioid therapy for migraine, low back pain, dental pain | Registry |
ACEP58 | Appropriate Treatment for Adults with Upper Respiratory Infection (URI) | Registry |
ACMS2 | Closing the Mohs Surgery Referral Loop: Transmission of Surgical Report | Registry |
ACMS3 | Antibiotic Prophylaxis for High Risk Cardiac / Orthopedic Cases prior to Mohs micrographic surgery - Prevention of Overuse | Registry |
ACMS4 | Surgical Site Infection Rate - Mohs Micrographic Surgery | Registry |
ACMS5 | Documentation of High-Risk Squamous Cell Carcinoma Stage in Mohs Micrographic Surgery Record | Registry |
ACMS8 | Limit quantity of opioids prescribed for pain management in patients following Mohs micrographic surgery | Registry |
ACQR12 | ABCDEF Bundle - Early mobility for ICU patients | Registry |
ACQR13 | Sepsis: Hour One bundle | Registry |
ACQR15 | Use of a risk stratification tool in patients with CAP | Registry |
ACQR16 | COPD Exacerbation or CHF Exacerbation requiring Hospital Admission: Palliative Care Evaluation | Registry |
ACQR3 | COPD: Steroids for no more than 5 days in COPD Exacerbation | Registry |
ACQR9 | Use of ACE-I or ARB and beta blockade in CHF | Registry |
ACR10 | Hepatitis B Safety Screening | Registry |
ACR12 | Disease Activity Measurement for Patients with PsA | Registry |
ACR14 | Gout: Serum Urate Target | Registry |
ACR15 | Safe Hydroxychloroquine Dosing | Registry |
ACR16 | Rheumatoid Arthritis Patients with Low Disease Activity or Remission | Registry |
ACRAD15 | Report Turnaround Time: Radiography | Registry |
ACRAD16 | Report Turnaround Time: Ultrasound (Excluding Breast US) | Registry |
ACRAD17 | Report Turnaround Time: MRI | Registry |
ACRAD18 | Report Turnaround Time: CT | Registry |
ACRAD19 | Report Turnaround Time: PET | Registry |
ACRAD25 | Report Turnaround Time: Mammography | Registry |
ACRAD34 | Multi-strata weighted average for 3 CT Exam Types: Overall Percent of CT exams for which Dose Length Product is at or below the size-specific diagnostic reference level (for CT Abdomen-pelvis with contrast/single phase scan, CT Chest without contrast/single phase scan and CT Head/Brain without contrast/single phase scan) | Registry |
ACRAD36 | Incidental Coronary Artery Calcification Reported on Chest CT | Registry |
ACRAD37 | Interpretation of CT Pulmonary Angiography (CTPA) for Pulmonary Embolism | Registry |
ACRAD38 | Use of Low Dose Cranial CT or MRI Examinations for Patients with Ventricular Shunts | Registry |
ACRAD39 | Use of Low Dose CT Studies for Adults with Suspicion of Urolithiasis or Nephrolithiasis | Registry |
ACRAD40 | Use of Structured Reporting in Prostate MRI | Registry |
ACRAD41 | Use of Quantitative Criteria for Oncologic FDG PET Imaging | Registry |
ACRAD42 | Surveillance Imaging for Liver Nodules <10mm in Patients at Risk for Hepatocellular Carcinoma (HCC) | Registry |
AHSQC10 | Ventral Hernia Repair: Pain and Functional Status Assessment | Registry |
AHSQC6 | Abdominal Wall Reconstruction Surgical Site Occurrence Requiring Procedural Intervention within the 30 Day Postoperative Period | Registry |
AJRR3 | Hip Arthroplasty: Shared Decision-Making: Trial of Conservative (Non-surgical) Therapy | Registry |
AJRR4 | Hip Arthroplasty: Venous Thromboembolic and Cardiovascular Risk Evaluation | Registry |
AJRR6 | Hip/Knee Arthroplasty: Unplanned Readmission within 90 Days Following the Primary Procedure | Registry |
AJRR7 | Hip/Knee Replacement: Postoperative Ambulation | Registry |
AQI18 | Coronary Artery Bypass Graft (CABG): Prolonged Intubation – Inverse Measure | Registry |
AQI48 | Patient-Reported Experience with Anesthesia | Registry |
AQI49 | Adherence to Blood Conservation Guidelines for Cardiac Operations using Cardiopulmonary Bypass (CPB) – Composite | Registry |
AQI55 | Team-Based Implementation of a Care-and-Communication Bundle for ICU Patients | Registry |
AQI56 | Use of Neuraxial Techniques and/or Peripheral Nerve Blocks for Total Knee Arthroplasty (TKA) | Registry |
AQI57 | Safe Opioid Prescribing Practices | Registry |
AQI62 | Obstructive Sleep Apnea: Patient Education | Registry |
AQI65 | Avoidance of Cerebral Hyperthermia for Procedures Involving Cardiopulmonary Bypass | Registry |
AQI67 | Consultation for Frail Patients | Registry |
AQI68 | Obstructive Sleep Apnea: Mitigation Strategies | Registry |
AQI69 | Intraoperative Antibiotic Redosing | Registry |
AQI70 | Prevention of Arterial Line-Related Bloodstream Infections | Registry |
AQI71 | Ambulatory Glucose Management | Registry |
AQI72 | Perioperative Anemia Management | Registry |
AQUA14 | Stones: Inappropriate Repeat Shock Wave Lithotripsy (SWL) Within 6 Months of Initial Treatment | Registry |
AQUA15 | Stones: Urinalysis Performed Before Surgical Stone Procedures | Registry |
AQUA16 | Non-Muscle Invasive Bladder Cancer: Repeat Transurethral Resection of Bladder Tumor (TURBT) for T1 disease | Registry |
AQUA18 | Non-Muscle Invasive Bladder Cancer: Early Surveillance Cystoscopy for Non-Muscle Invasive Bladder Cancer | Registry |
AQUA26 | Benign Prostate Hyperplasia (BPH): Inappropriate Lab & Imaging Services for Patients with BPH | Registry |
AQUA8 | Hospital admissions/complications within 30 days of TRUS Biopsy | Registry |
ASPS10 | Patient Satisfaction with Information Provided during Breast Reconstruction | Registry |
ASPS16 | Airway Assessment for patients undergoing Rhinoplasty | Registry |
ASPS17 | Patient Satisfaction with Rhinoplasty Procedure | Registry |
ASPS18 | Shared-decision making for post-operative management of discomfort following Rhinoplasty | Registry |
ASPS22 | Coordination of Care for Anticoagulated Patients Undergoing Reconstruction After Skin Cancer Resection | Registry |
ASPS24 | Visits to the ER or Urgent Care Following Reconstruction After Skin Cancer Resection | Registry |
ASPS26 | Patient Satisfaction with Information Prior to Facial Reconstruction After Skin Cancer Resection Procedures | Registry |
ASPS27 | Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Procedures | Registry |
ASPS28 | Continuation of Anticoagulation Therapy in the Office-based Setting for Closure and Reconstruction After Skin Cancer Resection Procedures | Registry |
ASPS29 | Avoidance of Opioid Prescriptions for Closure and Reconstruction After Skin Cancer Resection | Registry |
ASPS5 | Breast Reconstruction: Return to OR | Registry |
CAP22 | Turnaround Time (TAT) - Biopsies | Registry |
CAP28 | Helicobacter pylori Status and Turnaround Time | Registry |
CAP30 | Urinary Bladder Biopsy Diagnostic Requirements For Appropriate Patient Management | Registry |
CAP32 | Prostate Cancer Gleason Pattern, Score, and Grade Group | Registry |
CAP33 | Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing Status in Colorectal Carcinoma, Endometrial, Gastroesophageal, or Small Bowel Carcinoma | Registry |
CAP34 | Biomarker Status to Inform Clinical Management and Treatment Decisions in Patients with Non-small Cell Lung Cancer | Registry |
CAP35 | Cancer Protocol and Turnaround Time for Gastrointestinal Carcinomas: Gastric, Esophageal, Colorectal and Hepatocellular Carcinomas | Registry |
CAP36 | p16 Immunohistochemistry Reporting for Human Papillomavirus in Patients with Oropharyngeal Squamous Cell Carcinoma (OPSCC) | Registry |
CAP37 | Cancer Protocol and Turnaround Time for Gynecologic and Genitourinary Carcinomas: Carcinoma of the Endometrium, Prostate, and Renal Tubular Origin | Registry |
CCOME1 | Patient-Reported Pain and/or Function Improvement after Total Knee Arthroplasty | Registry |
CCOME4 | Patient-Reported Pain and/or Function Improvement after ACLR Surgery | Registry |
CCOME5 | Extent of Osteoarthritis Observed in Arthroscopic Partial Meniscectomy | Registry |
CCOME6 | Patient-Reported Pain and/or Function Improvement after APM Surgery | Registry |
CCOME7 | Patient-Reported Pain and/or Function Improvement after Total Hip Arthroplasty | Registry |
CCOME8 | Patient-Reported Pain and/or Function Improvement after Total Shoulder Arthroplasty | Registry |
CDR1 | Adequate Off-loading of Diabetic Foot Ulcer at each visit | Registry |
CDR2 | Diabetic Foot Ulcer (DFU) Healing or Closure | Registry |
CDR5 | Adequate Compression at each visit for Patients with VLUs | Registry |
CDR6 | Venous Leg Ulcer (VLU) outcome measure: Healing or Closure | Registry |
CDR8 | Appropriate Use of hyperbaric oxygen therapy for patients with diabetic foot ulcers | Registry |
CESQIP1 | Post operative hypocalcemia after thyroidectomy surgery | Registry |
CESQIP3 | Pre operative ultrasound exam of patients with thyroid cancer | Registry |
CESQIP5 | Related readmission for adrenal related problems | Registry |
CESQIP9 | qPTH >50% Reduction at End of Procedure | Registry |
ECPR39 | Avoid Head CT for Patients with Uncomplicated Syncope | Registry |
ECPR40 | Initiation of the Initial Sepsis Bundle | Registry |
ECPR41 | Rh Status Evaluation and Treatment of Pregnant Women at Risk of Fetal Blood Exposure | Registry |
ECPR46 | Avoidance of Opiates for Low Back Pain or Migraines | Registry |
ECPR50 | Door to Diagnostic Evaluation by a Provider Within 30 Minutes – Urgent Care Patients | Registry |
ECPR51 | Discharge Prescription of Naloxone after Opioid Poisoning or Overdose | Registry |
ECPR52 | Appropriate Treatment of Psychosis and Agitation in the Emergency Department | Registry |
ECPR53 | Clinician Reporting of Loss of Consciousness to State Department of Public Health or Department of Motor Vehicles | Registry |
ECPR54 | Avoidance of Co-Prescribing of Opioid Analgesic and Benzodiazepine | Registry |
ECPR55 | Avoidance of Long-Acting (LA) or Extended-Release (ER) Opiate Prescriptions and Opiate Prescriptions for Greater Than 3 Days Duration for Acute Pain | Registry |
ECPR56 | Opioid Withdrawal: Initiation of Medication-Assisted Treatment (MAT) and Referral to Outpatient Opioid Treatment | Registry |
EPREOP30 | Ultrasound Guidance for Peripheral Nerve Block with Patient Experience | Registry |
EPREOP31 | Intraoperative Hypotension among Non-Emergent Noncardiac Surgical Cases | Registry |
FORCE21 | Review of Pain Status Assessment for Patients with Osteoarthritis | Registry |
FOTO2 | Functional Status Change for Patients Post Stroke: Lower Body | Registry |
FOTO3 | Functional Status Change for Patients Post Stroke: Upper Body | Registry |
FOTO4 | Functional Status Changes for Patients with Upper or Lower Extremity Regional Swelling | Registry |
GIQIC10 | Appropriate management of anticoagulation in the peri-procedural period rate – EGD | Registry |
GIQIC22 | Screening Colonoscopy Adenoma Detection Rate | Registry |
GIQIC23 | Appropriate follow-up interval based on pathology findings in screening colonoscopy | Registry |
HCPR14 | Venous Thromboembolism (VTE) Prophylaxis | Registry |
HCPR16 | Physician’s Orders for Life-Sustaining Treatment (POLST) Form | Registry |
HCPR17 | Pressure Ulcers – Risk Assessment and Plan of Care | Registry |
HCPR18 | Unintentional Weight Loss – Risk Assessment and Plan of Care | Registry |
HCPR20 | Clostridium Difficile – Risk Assessment and Plan of Care | Registry |
HCPR22 | Critical Care Transfer of Care – Use of Verbal Checklist or Protocol | Registry |
HCPR23 | Avoidance of Echocardiogram and Carotid Ultrasound for Syncope | Registry |
HM10 | Outcomes of Hearing Loss Treatment | Registry |
HM11 | Outcomes of Treatment of Subjective Tinnitus | Registry |
HM12 | Outcomes of Treatment of Benign Paroxysmal Positional Vertigo | Registry |
HM4 | Functional Status Change for Patients With Upper-limb Functional Status Deficit | Registry |
HM5 | Functional Status Change for Patients With Neck Functional Status Deficit | Registry |
HM6 | Functional Status Change for Patients With Low Back Functional Status Deficit | Registry |
HM7 | Functional Status Change for Patients with Vestibular Dysfunction | Registry |
HM8 | Functional Status Change for Patients With Lower Extremity Functional Status Deficit | Registry |
HM9 | Functional Benefit of a Cochlear Implant | Registry |
IGR1 | Comprehensive TTE studies reporting a measured value of LVEF AND wall motion findings with LVEF < 50% | Registry |
IGR10 | Transthoracic Echo (TTE) performance per ASE guidelines | Registry |
IGR12 | Appropriate diagnosis verification and severity grading for valve disease through transthoracic echocardiography (TTE) quantitative parameters. | Registry |
IGR14 | Appropriate Evaluation of Left Ventricular Structure and Systolic Function with Transthoracic Echocardiography (TTE) to Guide Heart Failure and Cardiomyopathy Management | Registry |
IGR15 | Myocardial Perfusion Imaging (MPI) or Stress Echocardiography Imaging Studies - Adequate Exercise Protocol | Registry |
IGR16 | Myocardial Perfusion Imaging (MPI) Studies, Transthoracic Echo (TTE), or Stress Echocardiography Imaging Studies - Adequate Reporting for Appropriate Interventions | Registry |
IGR17 | Myocardial Perfusion Imaging (MPI) studies - Radiation Reduction Strategies | Registry |
IGR18 | Myocardial Perfusion Imaging (MPI) or Stress Echocardiography imaging studies - Improving Image Quality | Registry |
IGR2 | Parameters in stress echocardiography dobutamine testing for low flow, low gradient aortic stenosis | Registry |
IGR9 | Stress echo performance for shortness of breath per ASE guidelines | Registry |
IRIS1 | Endothelial Keratoplasty - Post-operative improvement in best corrected visual acuity to 20/40 or better | Registry |
IRIS13 | Diabetic Macular Edema - Loss of Visual Acuity | Registry |
IRIS17 | Acute Anterior Uveitis: Post-treatment Grade 0 anterior chamber cells | Registry |
IRIS2 | Glaucoma – Intraocular Pressure Reduction | Registry |
IRIS23 | Refractive Surgery: Patients with a postoperative uncorrected visual acuity (UCVA) of 20/20 or better within 30 days | Registry |
IRIS24 | Refractive Surgery: Patients with a postoperative correction within + or - 0.5 Diopter (D) of the intended correction | Registry |
IRIS26 | Avoidance of Routine Antibiotic Use in Patients Before or After Intravitreal Injections | Registry |
IRIS35 | Improvement of Macular Edema in Patients with Uveitis | Registry |
IRIS38 | Endothelial Keratoplasty – Dislocation Requiring Surgical Intervention | Registry |
IRIS39 | Intraocular Pressure Reduction Following Trabeculectomy or an Aqueous Shunt Procedure | Registry |
IRIS41 | Improved visual acuity after epiretinal membrane treatment within 120 days | Registry |
IRIS43 | Intraocular Pressure Reduction Following Laser Trabeculoplasty | Registry |
IRIS44 | Visual Field Progression in Glaucoma | Registry |
IRIS45 | Exudative Age-Related Macular Degeneration: Loss of Visual Acuity | Registry |
IRIS46 | Evidence of anatomic closure of macular hole within 90 days after surgery as documented by OCT | Registry |
IRIS48 | Adult Surgical Esotropia: Postoperative alignment | Registry |
IRIS49 | Surgical Pediatric Esotropia: Postoperative alignment | Registry |
IRIS5 | Surgery for Acquired Involutional Ptosis: Patients with an improvement of marginal reflex distance (MRD) | Registry |
IRIS50 | Amblyopia: Interocular visual acuity | Registry |
IRIS51 | Acute Anterior Uveitis: Post-treatment visual acuity | Registry |
IRIS52 | Post-operative opioid management following ocular surgery | Registry |
IRIS53 | Chronic Anterior Uveitis - Post-treatment visual acuity | Registry |
IRIS54 | Complications After Cataract Surgery | Registry |
IRIS55 | Visual Acuity Improvement Following Cataract Surgery and Minimally Invasive Glaucoma Surgery | Registry |
IRIS56 | Adult Diplopia: Improvement of ocular deviation or absence of diplopia or functional improvement | Registry |
IRIS57 | Idiopathic Intracranial Hypertension: Improvement of mean deviation or stability of mean deviation | Registry |
IRIS58 | Improved Visual Acuity after Vitrectomy for Complications of Diabetic Retinopathy within 120 Days | Registry |
IRIS59 | Regaining Vision After Cataract Surgery | Registry |
IRIS6 | Acquired Involutional Entropion: Normalized lid position after surgical repair | Registry |
IRIS60 | Visual Acuity Improvement Following Cataract Surgery Combined with a Trabeculectomy or an Aqueous Shunt Procedure | Registry |
IROMS11 | Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in knee rehabilitation of patients with knee injury measured via their validated Knee Outcome Survey (KOS) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published MCID. | Registry |
IROMS12 | Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with knee injury pain. | Registry |
IROMS13 | Failure to Progress (FTP): Proportion of patients not achieving a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with hip, leg or ankle injuries using the validated Lower Extremity Function Scale (LEFS) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published MCID. | Registry |
IROMS14 | Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with hip, leg or ankle (lower extremity except knee) injury. | Registry |
IROMS15 | Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with neck pain/injury measured via the validated Neck Disability Index (NDI). | Registry |
IROMS16 | Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with neck pain/injury. | Registry |
IROMS17 | Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation patients with low back pain measured via the validated Modified Low Back Pain Disability Questionnaire (MDQ) score. | Registry |
IROMS18 | Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with low back pain. | Registry |
IROMS19 | Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with arm, shoulder, and hand injury measured via the validated Disability of Arm Shoulder and Hand (DASH) score, Quick Disability of Arm Shoulder and Hand (QDASH) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published MCID. | Registry |
IROMS20 | Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with arm, shoulder, or hand injury. | Registry |
MBHR1 | Use of Anxiety Severity Measure | Registry |
MBHR10 | Symptom Improvement in adults with ADHD | Registry |
MBHR11 | Cognitive Assessment with Counseling on Safety and Potential Risk | Registry |
MBHR12 | Patient Feedback of Test Results Following Cognitive or Mental Status Assessment | Registry |
MBHR2 | Anxiety Response at 6-months | Registry |
MBHR3 | Pain Interference Response utilizing PROMIS | Registry |
MBHR4 | Social Role Functioning Outcome utilizing PROMIS | Registry |
MBHR5 | Screening and monitoring for psychosocial problems among children and youth | Registry |
MBHR6 | Sleep Quality Assessment and Sleep Response at 3-months | Registry |
MBHR7 | Posttraumatic Stress Disorder (PTSD) Outcome Assessment for Adults and Children | Registry |
MBHR8 | Alcohol Use Disorder Outcome Response | Registry |
MBHR9 | Outcome monitoring of ADHD functional impairment in children and youth | Registry |
MEDNAX53 | Use of Capnography for Non-Operating Room Anesthesia | Registry |
MEDNAX54 | Labor Epidural Failure when Converting from Labor Analgesia to Cesarean Section Anesthesia | Registry |
MEDNAX55 | Use of ASPECTS (Alberta Stroke Program Early CT Score) for non-contrast CT Head performed for suspected acute stroke. | Registry |
MEDNAX56 | Use of a “PEG Test” to Manage Patients Receiving Opioids | Registry |
MEX5 | Hammer Toe Outcome | Registry |
MSN13 | Screening Coronary Calcium Scoring for Cardiovascular Risk Assessment Including Coronary Artery Calcification Regional Distribution Scoring | Registry |
MSN15 | Use of Thyroid Imaging Reporting & Data System (TI-RADS) in Final Report to Stratify Thyroid Nodule Risk | Registry |
MSN16 | Screening Abdominal Aortic Aneurysm Reporting with Recommendations | Registry |
MUSIC10 | Prostate Cancer: Confirmation Testing in low risk AS eligible patients | Registry |
MUSIC11 | Prostate Cancer: Follow-Up Testing for patients on active surveillance for at least 30 months | Registry |
MUSIC12 | Kidney Stones: ED visit within 30 days of ureteroscopy | Registry |
MUSIC15 | Kidney Stones: SWL in patients with largest renal stone > 2 cm or lower pole stone > 1 cm | Registry |
MUSIC17 | Kidney Stones: Opioid utilization after ureteroscopy and shockwave lithotripsy | Registry |
MUSIC18 | Kidney Stones: Alpha-blockers at discharge for patients undergoing ureteroscopy or shockwave lithotripsy | Registry |
MUSIC19 | Kidney Stones: Readmission within 30 days of ureteroscopy | Registry |
MUSIC20 | Prostate Cancer: Complications within 30 days of radical prostatectomy | Registry |
MUSIC21 | Prostate Cancer: Opioid utilization after radical prostatectomy | Registry |
MUSIC22 | Prostate Cancer: Urinary continence at 12 months post-radical prostatectomy | Registry |
MUSIC23 | Renal Mass: Documentation of the RENAL score for patients with small renal mass diagnoses | Registry |
MUSIC24 | Kidney Stones: Post-ureteroscopy and shockwave lithotripsy imaging for any stones | Registry |
MUSIC25 | Renal Mass: ED visit or Readmission within 30 days of radical nephrectomy | Registry |
MUSIC26 | Renal Mass: ED Visit or Readmission within 30 days of partial nephrectomy | Registry |
MUSIC4 | Prostate Cancer: Active Surveillance/Watchful Waiting for Low Risk Prostate Cancer Patients | Registry |
MUSIC5 | Prostate Cancer: Radical Prostatectomy Cases LOS | Registry |
NHCR4 | Repeat screening or surveillance colonoscopy recommended within one year due to inadequate/poor bowel preparation | Registry |
NIPM18 | CHANGE IN PATIENT REPORTED QUALITY OF LIFE FOLLOWING EPIDURAL LYSIS OF ADHESIONS | Registry |
NIPM19 | CHANGE IN PATIENT REPORTED QUALITY OF LIFE AND FUNCTIONAL STATUS FOLLOWING MEDIAL BRANCH RADIOFREQUENCY ABLATION | Registry |
NIPM20 | CHANGE IN PATIENT REPORTED PAIN AND FUNCTIONAL STATUS FOLLOWING SPINAL CORD STIMULATOR IMPLANTATION | Registry |
NIPM22 | CHANGE IN PATIENT REPORTED QUALITY OF LIFE FOLLOWING EPIDURAL CORTICOSTEROID INJECTION | Registry |
NIPM23 | CHANGE IN PATIENT REPORTED QUALITY OF LIFE FOLLOWING MAJOR JOINT CORTICOSTEROID INJECTION | Registry |
NIPM24 | CHANGE IN PATIENT REPORTED QUALITY OF LIFE FOLLOWING INTRATHECAL PUMP IMPLANTATION | Registry |
NIPM25 | CHANGE IN PATIENT REPORTED QUALITY OF LIFE FOLLOWING INTERSPINOUS INDIRECT DECOMPRESSION (SPACER) | Registry |
NPQR1 | Notification to the ordering provider requesting myoglobin or CK-MB in the diagnosis of suspected acute myocardial infarction (AMI) | Registry |
NPQR11 | Rate of communicating results of an amended report with a major discrepancy to the responsible provider | Registry |
NPQR13 | Rate of notification to clinical provider of a new diagnosis of malignancy | Registry |
NPQR15 | Non-small cell lung carcinoma (NSCLC) ancillary biomarker testing status and turnaround time (TAT) from point of specimen accession date to ancillary biomarker testing completion and reporting date should be ≤ 10 days | Registry |
NPQR16 | Notification to the provider ordering repeat blood chemistry panels in clinically stable patients within four days. | Registry |
NPQR17 | Notification to the provider ordering repeat C. difficile stool toxin testing within seven days | Registry |
NPQR18 | Notification to the provider ordering repeat CBCs in clinically stable patients within four days | Registry |
NPQR19 | Notification to the provider ordering repeat Hepatitis C serology testing on a patient with previously positive results | Registry |
NPQR2 | Notification to the ordering provider requesting thyroid screening tests other than only a Thyroid Stimulating Hormone (TSH) test in the initial screening of a patient with a suspected thyroid disorder | Registry |
NPQR3 | Notification to the ordering provider requesting amylase testing in the diagnosis of suspected acute pancreatitis | Registry |
NPQR4 | Time interval: critical value reporting for chemistry | Registry |
NPQR5 | Time interval: critical value reporting for cerebrospinal fluid - white blood cell (CSF - WBC) | Registry |
NPQR6 | Time interval: critical value reporting for toxicology | Registry |
NPQR7 | Time interval: critical value reporting for troponin | Registry |
OBERD32 | Quality of Life - Physical Health Outcomes | Registry |
OEIS6 | Appropriate non-invasive arterial testing for patients with intermittent claudication who are undergoing a LE peripheral vascular intervention | Registry |
OEIS7 | Structured Walking Program Prior to Intervention for Claudication | Registry |
OEIS8 | Use of ultrasound guidance for vascular access | Registry |
ONSQIR21 | Patient Reported Health-Related Quality of Life (HRQoL) during Treatment for Advanced Cancer | Registry |
ONSQIR22 | PCR Test with MR2 or greater result (BCR-ABL1 transcript level <= 1% [IS]) for patients receiving TKI for at least 6 months for Chronic Myelogenous Leukemia | Registry |
ONSQIR23 | Assessment for and management of immune-related adverse events during cancer treatment with checkpoint inhibitors (ICPi) | Registry |
PIMSH1 | Oncology: Advance Care Planning in metastatic cancer patients | Registry |
PIMSH10 | Oncology: Hepatitis B serology testing and prophylactic treatment prior to receiving anti-CD20 targeting drugs | Registry |
PIMSH11 | Oncology: Utilization of PET, PET/CT, or CT scans for breast cancer stage 0, I, or II at any time during the course of evaluation and treatment | Registry |
PIMSH2 | Oncology: Utilization of GCSF in metastatic colorectal cancer | Registry |
PIMSH3 | Oncology: Combination chemotherapy recommended or received within 4 months of diagnosis by women under 70 with AJCC stage T1cN0M0 to Stage 1B-III ER/PR negative breast cancer | Registry |
PIMSH4 | Oncology: Patient-reported pain improvement | Registry |
PIMSH8 | Oncology: Mutation testing for lung cancer completed prior to start of targeted therapy | Registry |
PIMSH9 | Oncology: Supportive care drug utilization in last 14 days of life | Registry |
PINC55 | Appropriate Documentation of a Malnutrition Diagnosis | Registry |
PINC56 | Assessment of Nutritionally At-Risk Patients for Malnutrition and Development of Nutrition Recommendations/Interventions by a Registered Dietitian Nutritionist | Registry |
PP8 | Measurement-based Care Processes: Baseline Assessment, Monitoring and Treatment Adjustment | Registry |
PP9 | Improvement or Maintenance of Functioning for Individuals with a Mental Health and/or Substance Use Disorder | Registry |
QMM16 | IVC Filter Management Confirmation | Registry |
QMM17 | Appropriate Follow-up Recommendations for Ovarian-Adnexal Lesions using the Ovarian-Adnexal Reporting and Data System (O-RADS) | Registry |
QMM18 | Use of Breast Cancer Risk Score on Mammography | Registry |
QMM19 | DEXA/DXA and Fracture Risk Assessment for Patients with Osteopenia | Registry |
QMM20 | Opening Pressure in Lumbar Puncture | Registry |
QOPI23 | Concurrent Chemo radiation for Patients with a Diagnosis of Stage IIIB NSCLC | Registry |
QOPI26 | Sentinel Lymph Node (SLN) Biopsies for Patients AJCC T1b-T4 Melanoma | Registry |
QOPI27 | Appropriate Antiemetic Therapy for High- and Moderate Emetic Risk Antineoplastic Agents | Registry |
QUANTUM31 | Central Line Ultrasound Guidance | Registry |
RCOIR10 | Upper Extremity Edema Improvement | Registry |
RCOIR12 | Tunneled Hemodialysis Catheter Success | Registry |
RCOIR13 | Percutaneous Arteriovenous Fistula for Dialysis - Clinical Success Rate | Registry |
RCOIR5 | End Stage Renal Disease (ESRD) Initiation of Home Dialysis or Self-Care | Registry |
RCOIR7 | Improved Access Site Bleeding | Registry |
REGCLR1 | Heel Pain Treatment Outcomes for Adults | Registry |
REGCLR2 | Tendinitis/ Enthesopathy- Injection Treatment Outcomes for Adults | Registry |
REGCLR3 | Bunion Outcome - Adult and Adolescent | Registry |
REGCLR4 | Heel Pain Treatment Outcomes for Pediatric Patients | Registry |
REGCLR5 | Offloading with Remote Monitoring | Registry |
REGCLR6 | Use of Digital Imaging to Monitor and Improve Treatment Outcomes in Chronic Wound Healing | Registry |
REGCLR7 | Use of Ankle Foot Orthotics to improve patient function | Registry |
RPAQIR13 | Rate of Timely Documentation Transmission to Dialysis Unit/Referring Physician | Registry |
RPAQIR14 | Arteriovenous Graft Thrombectomy Success Rate | Registry |
RPAQIR15 | Arteriovenous Fistulae Thrombectomy Success Rate | Registry |
RPAQIR16 | Peritoneal Dialysis Catheter Success Rate | Registry |
RPAQIR18 | Advance Directives Completed | Registry |
RPAQIR5 | Transplant Referral | Registry |
SPINETRACK4 | Percent of patients meeting SCB thresholds for back or neck pain | Registry |
SPINETRACK5 | Percent of patients meeting SCB thresholds for leg or arm pain | Registry |
SPINETRACK6 | Percent of patients meeting SCB thresholds for pain-related disability (ODI/NDI) | Registry |
SPINETRACK8 | Patient satisfaction following spinal fusion surgery | Registry |
SPINETRACK9 | Unplanned hospital readmission following spinal fusion surgery. | Registry |
STS1 | Prolonged Length of Stay Following Coronary Artery Bypass Grafting | Registry |
STS7 | Patient Centered Surgical Risk Assessment and Communication for Cardiac Surgery | Registry |
UREQA1 | Ankylosing Spondylitis: Controlled Disease | Registry |
UREQA2 | Ankylosing Spondylitis: Appropriate Pharmacologic Therapy | Registry |
UREQA4 | Folic or Folinic Acid Therapy for Patients Treated with Methotrexate | Registry |
USWR22 | Patient Reported Nutritional Assessment in Patients with Wounds and Ulcers | Registry |
USWR23 | Non Invasive Arterial Assessment of patients with lower extremity wounds or ulcers for determination of healing potential | Registry |
USWR24 | Patient Reported Experience of Care: Wound Outcome | Registry |
USWR25 | Pressure Ulcer* (PU) Healing or Closure for ulcers on the torso (body) | Registry |
USWR26 | Patient Reported Outcome of late effects of radiation symptoms following treatment with Hyperbaric Oxygen Therapy (HBOT) | Registry |
USWR27 | Assessment of Nutritionally At-Risk Patients for Malnutrition and Development of Nutrition Recommendations/Interventions by a Registered Dietitian Nutritionist | Registry |
USWR28 | Obtaining Preoperative Nutritional Recommendations from a Registered Dietitian Nutritionist (RDN) in Nutritionally At-Risk Surgical Patients | Registry |
WCHQ10 | Diabetes Care All or None Outcome Measure: Optimal Control | Registry |
WCHQ9 | Diabetes Care All or None Process Measure: Optimal Testing | Registry |